Detta kommer att spela en video - Doctor visiting patient with white beard

SYMPTOMATIC AORTIC STENOSIS CAN‘T WAIT

An urgent evaluation is everything.

CONTACT US FOR MORE INFORMATION

350,000 Est. Incidence

Today, 350,000 people in Western Europe develop annually symptomatic severe aortic stenosis (SSAS).1-9

Download Brochure
Aortic Stenosis Data
Medtronic transcatheter aortic valve replacement (TAVR) infographic noting that once severe symptoms of symptomatic aortic stenosis appear, survival is cut short.

MEDICAL MANAGEMENT ISN’T ENOUGH

After developing symptomatic severe aortic stenosis, the average patient survival is two years without treatment. 12 

SYMPTOMATIC AORTIC STENOSIS CAN BE FATAL

Aortic stenosis is among the most common of all valvular heart diseases and continues to increase as our population ages.13 
Symptomatic severe aortic stenosis (SSAS) can be fatal if left untreated.

EARLY DIAGNOSIS AND TREATMENT CAN MEAN BETTER OUTCOMES

Stethoscope image on the Medtronic transcatheter aortic valve replacement (TAVR) page.

DUE TO THE FOLLOWING FACTORS, SSAS ISN'T ALWAYS EASY TO DIAGNOSE:

  • Heart murmurs go undetected.14
  • Referrals are delayed or too late.14
  • Echocardiogram findings are misclassified due to complex cardiac anatomy.14
  • Patients don't recognise or report their symptoms.15
  • Patients refuse treatment.16
Medtronic TAVR graph noting the operated versus unoperated survival rates of aortic valve replacement over a 5-year span.

AORTIC VALVE REPLACEMENT GREATLY IMPROVES THE RATE OF SURVIVAL

Mortality difference for people with symptoms of aortic stenosis treated with aortic valve replacement versus those not undergoing this procedure is one of the most striking in medicine.17

URGENCY IS EVERYTHING FOR SYMPTOMATIC AORTIC STENOSIS PATIENTS

MIND THE MURMUR

You can help save more lives by recognising the symptoms of SSAS early on.

Infographic for symptomatic aortic stenosis reminding physicians to listen for the murmur, order an echocardiogram, and refer patients to a heart valve team immediately.

REFER YOUR SSAS PATIENTS TO THE HEART VALVE TEAM

FOLLOW ESC/EACTS GUIDELINES

ESC/EACTS Valvular Heart Disease Guidelines: Class 1B recommendation: Patient with symptomatic severe high-gradient aortic stenosis should be treated. The treatment choice should be made by the Heart Team according to the individual patient characteristics.18

DOWNLOAD ESC/EACTS DECISION TREE

The role of the Heart Team is essential to take all of these data into account and adopt a final decision on the best treatment strategy.18

ESC/EACTS Valvular Heart Disease Guidelines
Male doctor smiling while visiting old lady
Image of patient data

UNDERSTANDING SYMPTOMATIC AORTIC STENOSIS FROM A PATIENT POINT OF VIEW

It's easier to help patients when you know what they're thinking. The insights gathered from a new national survey conducted by Heart-Valve-Surgery.com, with support from Medtronic, can help you better understand the heart valve patient experience.

Share this resource with your patients: Heart-Valve-Surgery.com can help them learn more about their condition and find a supportive community of other patients diagnosed with SSAS.

Fill in the form below to contact us

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

View our privacy statement

1

STS Adult Cardiac Database. 2010 Harvest, Isolated AVR.

2

Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. November 13, 2007;50(20):2018-2019.

3

Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. June 21, 2005;111(24):3290-3295.

4

Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. May 2006;15(3):312-321.

5

Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. September 16, 2006;368(9540):1005-1011.

6

Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. April 1993;21(5):1220-1225.

7

Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. November 20, 2013;310(19):2069-2077.

8

Medtronic data on file #1. 

9

lung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. July 2003;24(13):1231-1243. 

10

Durko AP, Osnabrugge RL, Van Mieghem NM, Milojevic M, Mylotte D, Nkomo VT, Pieter Kappetein A. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J. 2018 Jul 21;39(28):2635-2642. doi: 10.1093/eurheartj/ehy107. PMID: 29546396.

11

Everett RJ, et al. Timing of intervention in aortic stenosis: a review of current and future strategies. Heart Epub 2018 doi:10.1136/heartjnl-2017-312304

12

Modified from Lester SJ, Heilbron B, Gin K, Dodek A, Jue J. The natural history and rate of progression of aortic stenosis. Chest. April 1998;113(4):1109-1114.

13

Carabello BA, Paulus WJ. Aortic stenosis. Lancet. March 14, 2009;373(9667):956-966.

14

McCarthy CP, Phelan D, Griffin B. When does asymptomatic aortic stenosis warrant surgery? Assessment techniques. Cleve Clin J Med. April 2016;83(4):271-280.

15

Brennan JM. Under-treatment of Aortic Stenosis in the United States. Presented at TVT 2019; Chicago, IL.

16

Medtronic data on file #2.

17

Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. November 1982;66(5):1105-1110. 

18

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391. PMID: 28886619.

19

Active Living Awareness Initiative Survey. Survey included 3400 respondents. Available at: Heart-Valve-Surgery.com.